+ All Categories
Home > Documents > General Pharmacology (Pharmacodynamics- II)

General Pharmacology (Pharmacodynamics- II)

Date post: 03-Apr-2018
Category:
Upload: tadiwanashe-logan
View: 217 times
Download: 0 times
Share this document with a friend
34
DOSE DOSE   RESONSE CURVE RESONSE CURVE 1 . 1 . Graded dose Graded dose - - response curve response curve 2. Quantal (all or none ) curve 2. Quantal (all or none ) curve
Transcript
Page 1: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 1/34

DOSEDOSE – –RESONSE CURVERESONSE CURVE

1.1. Graded doseGraded dose--response curveresponse curve

2. Quantal (all or none ) curve2. Quantal (all or none ) curve

Page 2: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 2/34

Graded DoseGraded Dose--response Curveresponse Curve

1.1. Response is continuous and gradualResponse is continuous and gradual..

2.2. Curve is usually sigmoid in shape ( LogCurve is usually sigmoid in shape ( Log

dose or concentration).dose or concentration).

3.3. used to calculateused to calculateED50ED50

PotencyPotency

EfficacyEfficacy

Page 3: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 3/34

MEDIAN EFFECTIVE DOSE (ED50 ).MEDIAN EFFECTIVE DOSE (ED50 ).

is a dose of the drug that gives ais a dose of the drug that gives a

response equals to 50% of the maximalresponse equals to 50% of the maximal

response.response.

is a measure of theis a measure of the potencypotency..

Page 4: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 4/34

POTENCYPOTENCY

IsIs inverselyinversely proportional to ED 50.proportional to ED 50.

Is a measure (in weight) of the amount of Is a measure (in weight) of the amount of 

the drug required to produce an action of the drug required to produce an action of a given magnitude (a given magnitude (50% of the maximal50% of the maximal

response = ED50response = ED50).).

The smaller is the EC50, the more potentThe smaller is the EC50, the more potent

is the drug.is the drug.

Efficacy is more important than potency.Efficacy is more important than potency.

Page 5: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 5/34

Page 6: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 6/34

Page 7: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 7/34

EFFICACYEFFICACY

Depends on the number of drugDepends on the number of drug--

receptors formed.receptors formed.

Efficacy is more important than potency.Efficacy is more important than potency.

Page 8: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 8/34

Page 9: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 9/34

Page 10: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 10/34

Quantal (all or none ) curveQuantal (all or none ) curve

Shows the effect of the magnitude of Shows the effect of the magnitude of 

the dose on the proportion of patientsthe dose on the proportion of patientsresponding (responding (Quantal responsesQuantal responses).).

Used to determine doses to whichUsed to determine doses to which

most population respond.most population respond.

Page 11: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 11/34

Quantal (all or none ) curveQuantal (all or none ) curve

MEDIAN EFFECTIVE DOSE (ED50 ).MEDIAN EFFECTIVE DOSE (ED50 ).

is a dose of the drug that gives responseis a dose of the drug that gives response

in 50% of patients.in 50% of patients.

MEDIAN LETHAL DOSE ( LD 50 or TD 50)MEDIAN LETHAL DOSE ( LD 50 or TD 50)

is the dose of a drug required to produceis the dose of a drug required to producetoxicity in 50 % of patients.toxicity in 50 % of patients.

Page 12: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 12/34

THERAPEUTIC INDEXTHERAPEUTIC INDEX (TI)(TI)

Therapeutic index =Therapeutic index = LD50LD50

ED50ED50

Is a measure of safetyIs a measure of safety

Large value a wide margin of safety.Large value a wide margin of safety.PenicillinPenicillin

Small value a narrow margin of Small value a narrow margin of safetysafety warfarinwarfarin

If (TI) is equal to or less than one,If (TI) is equal to or less than one,

drug isdrug is ??????

Page 13: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 13/34

Page 14: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 14/34

Page 15: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 15/34

Page 16: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 16/34

AntagonistAntagonist

TypesTypes

¾¾ Physiological antagonist.Physiological antagonist.

¾¾ Chemical antagonist.Chemical antagonist.

¾¾ Pharmacological antagonist.Pharmacological antagonist.

Page 17: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 17/34

AntagonismAntagonism

¾¾ Physiological antagonism.Physiological antagonism.

¾¾

Chemical antagonism.Chemical antagonism.

¾¾ Pharmacological antagonism.Pharmacological antagonism.

CompetitiveCompetitive → Reversible.Reversible.

NonNon--competitivecompetitive → Irreversible.Irreversible.

Page 18: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 18/34

••Drug AntagonismDrug Antagonism

Chemical AntagonismChemical Antagonism

¾¾Simple chemical reaction.Simple chemical reaction.¾¾No receptor.No receptor.

ExamplesExamples¾¾Antacid &Antacid & tetracyclinestetracyclines..

¾¾ Heparin & proteamine sulfateHeparin & proteamine sulfate

¾¾ Iron & Deferoxamine.Iron & Deferoxamine.

Page 19: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 19/34

Physiological AntagonismPhysiological Antagonism

¾¾Physiological effect is antagonized.Physiological effect is antagonized.¾¾Drugs acting on different receptors:Drugs acting on different receptors:

¾¾NoradrenalineNoradrenaline → VasoconstrictionVasoconstriction → ↑ BP.BP.

¾¾HistamineHistamine → Relax vascular smoothRelax vascular smooth

musclemuscle→ ↓BPBP

¾¾Noradrenaline is used in anaphylactic shockNoradrenaline is used in anaphylactic shockto raise BP.to raise BP.

Page 20: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 20/34

PharmacologicalPharmacological AntagonismAntagonism

Two drugs compete for the same receptor.Two drugs compete for the same receptor.

The antagonist partially or completely preventsThe antagonist partially or completely prevents

the pharmacological agonist effect.the pharmacological agonist effect.Pharmacological antagonistPharmacological antagonist

¾¾CompetitiveCompetitiveReversibleReversible

¾¾NonNon--competitivecompetitive

IrreversibleIrreversible

Page 21: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 21/34

Page 22: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 22/34

Page 23: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 23/34

Page 24: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 24/34

Competitive AntagonistCompetitive Antagonist

¾¾ The antagonist dissociates rapidlyThe antagonist dissociates rapidlyfrom the receptor.from the receptor.

¾¾ The antagonist effect can be overcomeThe antagonist effect can be overcomeby increasing the agonist concentration.by increasing the agonist concentration.

¾¾ The doseThe dose--response curve is shifted toresponse curve is shifted to

right.right.

¾¾ DoseDose--Response curve is parallel.Response curve is parallel.

¾¾EmaxEmax is maintained.is maintained.

¾¾ e.g. acetylcholine and atropine.e.g. acetylcholine and atropine.

Page 25: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 25/34

Page 26: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 26/34

Irreversible noncompetitive AntagonistIrreversible noncompetitive Antagonist

¾¾The antagonist dissociates very slowly or The antagonist dissociates very slowly or not at all from the receptor .not at all from the receptor .

¾¾The action of antagonist cannot beThe action of antagonist cannot beovercome by increasing the agonistovercome by increasing the agonist

concentration .concentration .

¾¾ The doseThe dose--response curve is shifted toresponse curve is shifted to

right.right.

¾¾ The two curves are not parallel.The two curves are not parallel.

¾¾EmaxEmax is not maintained.is not maintained.

¾¾PhenoxybenzaminePhenoxybenzamine ..

ProdrugProdrug

Page 27: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 27/34

ProdrugProdrug

A drug that is pharmacologically inactive but isA drug that is pharmacologically inactive but is

chemically changed into active form in the bodychemically changed into active form in the bodyby the action of enzymes.by the action of enzymes.

DoseDose

The amount of a drug to produce an effect.The amount of a drug to produce an effect.

Therapeutic DoseTherapeutic Dose

The dose required to produce therapeutic effect.The dose required to produce therapeutic effect.

Toxic DoseToxic DoseThe dose which produce toxic effect.The dose which produce toxic effect.

Page 28: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 28/34

Variation in drug responseVariation in drug response

Drug resistanceDrug resistance

intoleranceintolerance

ToleranceTolerance

TachyphylaxisTachyphylaxis

IdiosyncrasyIdiosyncrasy

Page 29: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 29/34

DRUG RESISTANCEDRUG RESISTANCE

The loss of the effectiveness of The loss of the effectiveness of antimicrobial or antitumour drugs.antimicrobial or antitumour drugs.

INTOLERANCE (HYPEINTOLERANCE (HYPE--RACTIVITY)RACTIVITY)

¾¾ Increase in response within theIncrease in response within the

therapeutic dose.therapeutic dose.

¾¾ Orthostatic hypotension after Orthostatic hypotension after 

Chlorpromazine (tranquilizer).Chlorpromazine (tranquilizer).

Page 30: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 30/34

TOLERANCETOLERANCE

A gradual decrease in response toA gradual decrease in response to

repeated administration of a drug.repeated administration of a drug.

Slow in onset (takes days or weeks toSlow in onset (takes days or weeks to

develop).develop).

Original effect can be produced byOriginal effect can be produced by

increasing the dose.increasing the dose.

e.g. alcohols, morphine, barbiturates.e.g. alcohols, morphine, barbiturates.

TACHYPHYLAXISTACHYPHYLAXIS

Page 31: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 31/34

TACHYPHYLAXISTACHYPHYLAXIS

A decrease in response to the rapidlyA decrease in response to the rapidlyrepeated administration of a drug.repeated administration of a drug.

Rapid in onset.Rapid in onset.

Original effect cannot be reproduced evenOriginal effect cannot be reproduced even

with a larger dose of the drug.with a larger dose of the drug.

e.g. Be.g. B--agonists, ephedrine, amphetamine,agonists, ephedrine, amphetamine,

Page 32: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 32/34

RECEPTOR DESENSITIZATIONRECEPTOR DESENSITIZATION

DefinitionDefinition

Changes in the responsiveness of theChanges in the responsiveness of the

receptor upon repeated or continuousreceptor upon repeated or continuous

administration of the drug.administration of the drug.

Causes of desensitizationCauses of desensitization

Page 33: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 33/34

Causes of desensitizationCauses of desensitization

¾¾Excessive stimulation of the receptorsExcessive stimulation of the receptors

¾¾Genetic causes.Genetic causes.

¾¾

Down regulation of receptors.Down regulation of receptors.¾¾ Enzyme inductionEnzyme induction

Page 34: General Pharmacology (Pharmacodynamics- II)

7/29/2019 General Pharmacology (Pharmacodynamics- II)

http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 34/34

Causes of desensitizationCauses of desensitization

¾¾ Genetic causes.Genetic causes.

¾¾Down regulation of receptors.Down regulation of receptors.

(( Decrease in the total number of receptorsDecrease in the total number of receptorsavailableavailable).).

¾¾Enzyme inductionEnzyme induction

TypesTypes¾¾ ToleranceTolerance

¾¾ TachyphylaxisTachyphylaxis


Recommended